SCHEMBL7407787

SCHEMBL7407787

Cc1nc2sccn2c(=O)c1CCN1CCC(C(Nc2ccc(F)cc2)c2ccc(F)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 4/20 0.59
▸ TSHR P16473 4/20 0.59
▸ PKM P14618 4/20 0.59
▸ SMN1; SMN2 Q16637 4/20 0.59
▸ HTR2C P28335 4/20 0.59
▸ HTR2A P28223 4/20 0.59
▸ MAPT P10636 3/20 0.59
▸ TP53 P04637 3/20 0.59
▸ HTR1A P08908 3/20 0.59
▸ PMP22 Q01453 3/20 0.59
▸ DRD2 P14416 3/20 0.59
▸ HTR7 P34969 3/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ CYP2C9 P11712 2/20 0.59
▸ ALOX15 P16050 2/20 0.59
▸ DGKA P23743 2/20 0.59
▸ HSD17B10 Q99714 2/20 0.59
▸ TDP1 Q9NUW8 2/20 0.59
▸ MEN1 O00255 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15999621 0.88 HTR1A (0.65) CYP2D6TSHRPKMSMN1; SMN2HTR2C
SCHEMBL10919317 0.79 HTR2C (0.73) CYP2D6TSHRPKMSMN1; SMN2HTR2C
SCHEMBL20402682 0.78 DRD2 (0.64) CYP2D6TSHRPKMSMN1; SMN2HTR2C
SCHEMBL7142123 0.75 HTR2A (0.59) CYP2D6TSHRPKMSMN1; SMN2HTR2C
Ritanserin SCHEMBL49227 0.74 MAPT (1.00) CYP2D6TSHRPKMSMN1; SMN2HTR2C
SCHEMBL8804386 0.74 PKM (0.62) CYP2D6TSHRPKMSMN1; SMN2HTR2C
Hydrochloric Acid SCHEMBL9871521 0.74 HTR2C (0.65) CYP2D6TSHRPKMSMN1; SMN2HTR2C
Ritanserin SCHEMBL10598671 0.74 MAPT (0.98) CYP2D6TSHRPKMSMN1; SMN2HTR2C
SCHEMBL7283740 0.74 DRD2 (0.66) CYP2D6TSHRPKMSMN1; SMN2HTR2C
Hydrochloric Acid SCHEMBL10945457 0.73 HTR1A (0.64) CYP2D6TSHRPKMSMN1; SMN2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5198449-A N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents A. H. ROBINS COMPANY INCORPORATED (US) 1993-03-30 — — US disclosed
Send feedback